Home › Funds › ALTRINSIC GLOBAL ADVISORS LLC › GSK

ALTRINSIC GLOBAL ADVISORS LLC position in GSK

GSK PLC · Health Care

ALTRINSIC GLOBAL ADVISORS LLC reported holding 204 shares of GSK (GSK PLC) in its Q3 2026 13F filing — a position valued at US$10K, representing 0.00% of its reported portfolio and ranking #49 among its reported holdings. ALTRINSIC GLOBAL ADVISORS LLC has disclosed GSK holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)204 sh
Reported value held$9.83K
Portfolio Weight0.00%
First reportedQ2 2026
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How ALTRINSIC GLOBAL ADVISORS LLC's GSK position evolved

ALTRINSIC GLOBAL ADVISORS LLC first disclosed a stake in GSK in Q2 2026 at 204 shares (US$11K). Across 2 filings, ALTRINSIC GLOBAL ADVISORS LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 204 shares valued at US$10K.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 204 $10.69K New
Q3 2026 204 $9.83K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GSK and 13F data

GSK (GSK PLC) is a Health Care company. 19 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.08B), PRIMECAP MANAGEMENT CO/CA/ (US$1.21B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GSK

All GSK fund holders →

FAQ

How long has ALTRINSIC GLOBAL ADVISORS LLC held GSK?

ALTRINSIC GLOBAL ADVISORS LLC has disclosed GSK holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is ALTRINSIC GLOBAL ADVISORS LLC's current position in GSK?

As of Q3 2026, ALTRINSIC GLOBAL ADVISORS LLC holds 204 shares of GSK (GSK PLC), valued at $9.83K, representing 0.00% of its reported portfolio and ranking #49.

Has ALTRINSIC GLOBAL ADVISORS LLC been buying or selling GSK?

In the latest 13F filing (Q3 2026), ALTRINSIC GLOBAL ADVISORS LLC held unchanged its position in GSK.

Which other funds hold GSK?

Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 19 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.